These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31844767)
1. Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel. Odeh F; Naffa R; Azzam H; Mahmoud IS; Alshaer W; Al Bawab A; Ismail S Heliyon; 2019 Nov; 5(11):e02919. PubMed ID: 31844767 [TBL] [Abstract][Full Text] [Related]
2. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties, Shaarani S; Hamid SS; Mohd Kaus NH Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648 [TBL] [Abstract][Full Text] [Related]
3. Thymoquinone-loaded mesenchymal stem cell-derived exosome as an efficient nano-system against breast cancer cells. Ebrahimian M; Hashemi M; Etemad L; Salmasi Z Iran J Basic Med Sci; 2022 Jun; 25(6):723-731. PubMed ID: 35949303 [TBL] [Abstract][Full Text] [Related]
4. Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer. Moubarak MM; Chanouha N; Abou Ibrahim N; Khalife H; Gali-Muhtasib H World J Clin Oncol; 2021 May; 12(5):342-354. PubMed ID: 34131566 [TBL] [Abstract][Full Text] [Related]
5. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells. Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay. Barani M; Mirzaei M; Torkzadeh-Mahani M; Adeli-Sardou M Sci Rep; 2019 May; 9(1):7139. PubMed ID: 31073144 [TBL] [Abstract][Full Text] [Related]
7. Thymoquinone Could Increase The Efficacy of Tamoxifen Induced Apoptosis in Human Breast Cancer Cells: An In Vitro Study. Ganji-Harsini S; Khazaei M; Rashidi Z; Ghanbari A Cell J; 2016; 18(2):245-54. PubMed ID: 27540530 [TBL] [Abstract][Full Text] [Related]
8. In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes. Fahmy HM Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1465-1476. PubMed ID: 31377882 [TBL] [Abstract][Full Text] [Related]
9. The comparison of anticancer activity of thymoquinone and nanothymoquinone on human breast adenocarcinoma. Dehghani H; Hashemi M; Entezari M; Mohsenifar A Iran J Pharm Res; 2015; 14(2):539-46. PubMed ID: 25901162 [TBL] [Abstract][Full Text] [Related]
10. Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice. Ong YS; Saiful Yazan L; Ng WK; Noordin MM; Sapuan S; Foo JB; Tor YS Int J Nanomedicine; 2016; 11():5905-5915. PubMed ID: 27877037 [TBL] [Abstract][Full Text] [Related]
11. Thymoquinone-loaded lipid nanocapsules with promising anticancer activity for colorectal cancer. Selmi M; Salek A; Barboura M; Njim L; Trabelsi A; Lahmar A; Lautram N; Roger E; Baati T; Ghedira LC Nanoscale Adv; 2023 Sep; 5(19):5390-5398. PubMed ID: 37767034 [TBL] [Abstract][Full Text] [Related]
12. Investigating anti-cancer activity of dual-loaded liposomes with thymoquinone and vitamin C. Munef A; Lafi Z; Shalan N Ther Deliv; 2024 Apr; 15(4):267-278. PubMed ID: 38449422 [No Abstract] [Full Text] [Related]
13. Regressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone. Talib WH Sci Pharm; 2017 Jul; 85(3):. PubMed ID: 28671634 [TBL] [Abstract][Full Text] [Related]
14. Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer. Khan A; Alsahli MA; Aljasir MA; Maswadeh H; Mobark MA; Azam F; Allemailem KS; Alrumaihi F; Alhumaydhi FA; Alwashmi ASS; Almatroudi AA; Alsugoor MH; Khan MA Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057049 [TBL] [Abstract][Full Text] [Related]
15. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. Bhattacharya S; Ahir M; Patra P; Mukherjee S; Ghosh S; Mazumdar M; Chattopadhyay S; Das T; Chattopadhyay D; Adhikary A Biomaterials; 2015 May; 51():91-107. PubMed ID: 25771001 [TBL] [Abstract][Full Text] [Related]
16. Combinatorial effect of thymoquinone with chemo agents for tumor therapy. Jehan S; Huang J; Farooq U; Basheer I; Zhou W Phytomedicine; 2022 Apr; 98():153936. PubMed ID: 35114449 [TBL] [Abstract][Full Text] [Related]
17. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741 [TBL] [Abstract][Full Text] [Related]
18. Reverse Screening Bioinformatics Approach to Identify Potential Anti Breast Cancer Targets Using Thymoquinone from Neutraceuticals Black Cumin Oil. Sundaravadivelu S; Raj SK; Kumar BS; Arumugamand P; Ragunathan PP Anticancer Agents Med Chem; 2019; 19(5):599-609. PubMed ID: 30678630 [TBL] [Abstract][Full Text] [Related]
19. Low Doses of Thymoquinone and Ferulic Acid in Combination Effectively Inhibit Proliferation of Cultured MDA-MB 231 Breast Adenocarcinoma Cells. Al-Mutairi A; Rahman A; Rao MS Nutr Cancer; 2021; 73(2):282-289. PubMed ID: 32223348 [TBL] [Abstract][Full Text] [Related]
20. Nanocarriers: more than tour de force for thymoquinone. Rathore C; Rathbone MJ; Chellappan DK; Tambuwala MM; Pinto TJA; Dureja H; Hemrajani C; Gupta G; Dua K; Negi P Expert Opin Drug Deliv; 2020 Apr; 17(4):479-494. PubMed ID: 32077770 [No Abstract] [Full Text] [Related] [Next] [New Search]